🇺🇸 FDA

Company profile · Sponsor

Lakewood-Amedex

Lakewood-Amedex Biotherapeutics

LABT · NYSE pharma UNIVERSITY PARK, FL, USA
Pipeline
4
Drugs
0
Patents
8

Quick answer

Lakewood-Amedex (LABT) is a pharma company. headquartered in UNIVERSITY PARK, FL, USA. listed on NYSE. NovaPharmaNews links 4 pipeline programs, 0 drugs, and 8 patents to this profile..

Company facts

Ticker LABT
Exchange NYSE
Company type pharma
Headquarters UNIVERSITY PARK, FL, USA
SEC CIK 0002079272

Pipeline (4)

Search pipeline →

  1. 5% Bisphosphocin Topical Gel

    Lakewood-Amedex

    Chronic Diabetic Foot Ulcers

    phase 2 small molecule terminated

    1 trial

  2. 5% Nu-3 gel

    Lakewood-Amedex

    Diabetic Foot Infection

    phase 2 small molecule active

    1 trial

  3. Antimicrobial agent

    Lakewood-Amedex

    Diabetic Foot Ulcers (DFUs)

    phase 2 small molecule active

    1 trial

  4. Bisphosphocin Nu-3

    Lakewood-Amedex

    Diabetic Foot Infections

    phase 2 small molecule completed

    1 trial

Patents (8)

Search patents →

  1. US 12156883

    Bisphosphocin gel formulations and uses thereof

    Expires Mon Nov 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12054509

    Antimicrobial compounds, compositions, and uses thereof

    Expires Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12030908

    Antimicrobial compounds, compositions, and uses thereof

    Expires Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11795192

    Antimicrobial compounds, compositions, and uses thereof

    Expires Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11377468

    Antimicrobial compounds, compositions, and uses thereof

    Expires Mon Jun 30 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11123357

    Methods and compositions for treating oral mucositis

    Expires Mon Sep 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11096954

    Bisphosphocin gel formulations and uses thereof

    Expires Mon Aug 19 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10981943

    Antimicrobial compounds, compositions, and uses thereof

    Expires Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Lakewood-Amedex?

Lakewood-Amedex (LABT) is a pharma company. headquartered in UNIVERSITY PARK, FL, USA. listed on NYSE. NovaPharmaNews links 4 pipeline programs, 0 drugs, and 8 patents to this profile..

What pipeline programs does Lakewood-Amedex sponsor?

We track 4 ClinicalTrials.gov-linked programs for Lakewood-Amedex, including 5% Bisphosphocin Topical Gel and 3 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Lakewood-Amedex company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.